Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06NHI
|
||||
Former ID |
DNC004013
|
||||
Drug Name |
SB-213068
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551304] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H24N2O5
|
||||
Canonical SMILES |
CCOC(CC1=CC=C(C=C1)OCCN(C)C2=NC3=CC=CC=C3O2)C(=O)O
|
||||
InChI |
1S/C21H24N2O5/c1-3-26-19(20(24)25)14-15-8-10-16(11-9-15)27-13-12-23(2)21-22-17-6-4-5-7-18(17)28-21/h4-11,19H,3,12-14H2,1-2H3,(H,24,25)
|
||||
InChIKey |
FJENKDXEWRLENI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of PPAR-gamma | Target Info | Inhibitor | [551304] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.